SCOPOLAMINE TRANSDE

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC with CAGE code 1UNB0 for the procurement of 7.000 packages of Scopolamine Transdermal, identified by NSN 6505014562380, at a total price of $458.36. The order was issued on July 14, 2026, with a required delivery date of July 29, 2026, to Fort Bragg, North Carolina, under FOB destination terms, meaning the contractor bears all freight costs and risk until delivery. The unit price is $65.48 with zero tolerance for quantity variance, and acceptance is conducted by the government at the destination upon receipt. The contract references DFARS 252.232-7003 mandating electronic invoice submission likely through WAWF, with payment processed via the Defense Finance and Accounting Service in Columbus, Ohio, using payment office code SL4701 and accounting code BX: 97X4930 5CBX 001 2620 S33189. Packaging and marking requirements specify use of the manufacturer’s CAGE code and part number, adherence to the NSN, and shipping by traceable means only, explicitly prohibiting parcel post, though no MIL-STD packaging standards are cited. The awardee is listed as a merchant wholesaler under NAICS 424210, with no socioeconomic status or size certification disclosed, nor any special clauses, options, subcontracting requirements, or representations beyond basic commercial item procurement. The contracting officer is Lisa Quinn, with Shairy M. Cartagena serving as local administrator, but no official COR or COTR is identified. The basic contract is an IDIQ vehicle utilized for this low-value, high-turnover pharmaceutical delivery, consistent with a lowest price technically acceptable acquisition approach typical for DLA medical supply lines.